Turbinectomy: Partial Versus Mucosal Diathermy
Comparison of Outcomes of Partial Turbinectomy Versus Mucosal Diathermy in Patients With Inferior Turbinate Hypertrophy
1 other identifier
interventional
58
1 country
1
Brief Summary
Objectives: To compare the outcomes of partial turbinectomy versus mucosal diathermy in patients with inferior turbinate hypertrophy. Methodology: The ENT Department at Sheikh Zayed Hospital in Lahore carried out this non-randomized controlled study. Total 60 adults between the ages of 18 and 60 who have been diagnosed with inferior turbinate hypertrophy were included. Septal deviation, or other major sinonasal diseases; uncontrolled allergic rhinitis; prior nasal or turbinate surgery were excluded. In group A patients partial inferior turbinectomy (PIT) was done while in group B, submucosal diathermy (SMD) was done. A 10-point Visual Analogue Scale (VAS) was used to measure nose pain on the first postoperative day and at the one-month follow-up. Nasal obstruction scores (Grades 0-3) were assessed both before and after surgery at one and three months. Using Lund and Kennedy's standardized grading method, nasal crusting was assessed. At three-month follow-up visits, tissue healing quality was evaluated.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 26, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 25, 2025
CompletedFirst Submitted
Initial submission to the registry
February 26, 2026
CompletedFirst Posted
Study publicly available on registry
March 9, 2026
CompletedMarch 9, 2026
March 1, 2026
2 months
February 26, 2026
March 3, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Rate of Nasal Obstruction
one month
Incidence of Nasal Pain
one month
Rate of Nasal Crusting
one month
Study Arms (2)
partial turbinectomy
ACTIVE COMPARATORmucosal diathermy
EXPERIMENTALInterventions
After achieving adequate anesthesia and decongestion, the inferior turbinate will be visualized using a nasal speculum or endoscope. The medial one-third of the hypertrophied turbinate, including both the mucosal covering and underlying bony structure, will be carefully removed using turbinectomy scissors. The resection will be limited to the anterior two-thirds of the turbinate, avoiding injury to the posterior end. Bleeding points will be controlled using bipolar cautery or nasal packing as needed
Once the turbinate is exposed, an insulated diathermy needle will be inserted into the submucosal layer at the anterior end of the inferior turbinate. The needle will be advanced along the turbinate's length, staying close to the bone. A low-voltage coagulation current will be applied during withdrawal of the needle, typically in two to three passes to cover the superior, middle, and inferior aspects of the turbinate. This causes shrinkage of the submucosal tissue while keeping the outer mucosa mostly intact. Hemostasis will be ensured before the procedure is completed
Eligibility Criteria
You may qualify if:
- Confirmed diagnosis of inferior turbinate hypertrophy.
- Persistent nasal obstruction symptoms for over 6 months.
- Inadequate response to conservative medical treatments like intranasal corticosteroids and antihistamines for at least 3 months
You may not qualify if:
- Causes of nasal obstruction other than nasal polyps, septal deviation, sinusitis, or other major sinonasal diseases.
- Uncontrolled allergic rhinitis or undergoing immunotherapy.
- Previous nasal or turbinate surgery.
- Systemic diseases affecting nasal mucosa such as Wegener's granulomatosis, sarcoidosis, or cystic fibrosis.
- Pregnancy or breastfeeding.
- Bleeding disorders or use of anticoagulant therapy.
- Inability to adhere to the study protocol or cognitive impairments affecting understanding and compliance
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shaikh Zayed Hospital, Lahore
Lahore, Punjab Province, 60000, Pakistan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
mudassar saeed pansota
Assistant Professor of Urology, Shahida Islam Teaching Hospital, Lodhran, Pakistan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- clinical professor
Study Record Dates
First Submitted
February 26, 2026
First Posted
March 9, 2026
Study Start
September 27, 2025
Primary Completion
November 26, 2025
Study Completion
December 25, 2025
Last Updated
March 9, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share